{"id":"W3184807749","doi":"10.1016/j.clml.2021.07.020","title":"Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Sierra Oncology; Pfizer","keywords":"Medicine; Refractory (planetary science); Diffuse large B-cell lymphoma; Oncology; Internal medicine; Lymphoma; Oligonucleotide; Cancer research; DNA; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006478834,0.0002102534,0.0006606688,0.0002397602,0.0001570568,0.0003052933,0.0001663551,0.0003673044,0.001048816],"category_scores_gemma":[0.00104504,0.0000870295,0.0003211143,0.0001982466,0.0003128549,0.0002765278,0.0001146752,0.0007321527,0.0001936846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003217505,"about_ca_system_score_gemma":0.0003034576,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002912423,"about_ca_topic_score_gemma":0.0004832282,"domain_scores_codex":[0.9997472,0.0001324985,0.00001845155,0.00003437319,0.00003219659,0.00003525174],"domain_scores_gemma":[0.9994953,0.0002242871,0.0001018508,0.00003981624,0.00002823957,0.0001104831],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2889925,0.008254573,0.07896862,0.000708862,0.001208402,0.00110048,0.0004393295,0.004174938,0.1190346,0.0006555142,0.001728787,0.4947334],"study_design_scores_gemma":[0.0496362,0.6039409,0.2977638,0.000142394,0.001480307,0.003622235,0.0003083609,0.006905115,0.02416505,0.0008440451,0.01113022,0.00006136463],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960505,0.002384489,0.0001924212,0.0001303516,0.00002594327,0.00003895295,0.0001150637,0.00002197962,0.001040267],"genre_scores_gemma":[0.9989299,0.0004047921,0.000104636,0.0001085182,0.00003509621,0.00002097512,0.0001243906,0.000002991673,0.0002685888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001048816,"threshold_uncertainty_score":0.003508568,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0171050615275064,"score_gpt":0.2825302489685589,"score_spread":0.2654251874410525,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}